NCT03774771View on ClinicalTrials.gov

Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism

PHASE2CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 29, 1998

Primary Completion Date

December 13, 1999

Study Completion Date

December 13, 1999

Conditions

Primary Hyperparathyroidism

Interventions

DRUG

Cinacalcet

Capsule for oral administration

DRUG

Placebo

Capsules for oral administration

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY

NCT03774771 - Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter